Trial intelligence / Profile preview

Comparison of generic alginate vs original alginate in non-PPI responder GERD

TCTR20230119007Phase 3Unknown

Sponsor
Dr. Kawin Tangvoraphonkchai
Start
Feb 2023
Countries
1
01

Overview

Phase 3, randomised trial of alginic acid in gastroesophageal reflux disease (GERD) (2 arms), sponsored by Dr. Kawin Tangvoraphonkchai. Status: unknown.

02

Drugs

alginic acid
03

Conditions

gastroesophageal reflux disease (GERD)

Beyond the preview

Go deeper on TCTR20230119007.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20230119007.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call